Cargando…

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma

PURPOSE: Complex interactions occur between cancer cells and cells in the tumor microenvironment. In this study, the prognostic value of the interplay between tumor–stroma ratio (TSR) and the immune status of tumors in breast cancer patients was evaluated. METHODS: A cohort of 574 breast cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vangangelt, K. M. H., van Pelt, G. W., Engels, C. C., Putter, H., Liefers, G. J., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Kuppen, P. J. K., Mesker, W. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842256/ https://www.ncbi.nlm.nih.gov/pubmed/29273955 http://dx.doi.org/10.1007/s10549-017-4617-6

Ejemplares similares

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

Standardization of the tumor-stroma ratio scoring method for breast cancer research
por: Hagenaars, Sophie C., et al.
Publicado: (2022)

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
por: Vangangelt, Kiki M.H., et al.
Publicado: (2020)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
por: van Pelt, G. W., et al.
Publicado: (2018)

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study
por: Vogelaar, F. J., et al.
Publicado: (2016)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
por: Smit, Marloes A., et al.
Publicado: (2023)

Tumor stroma as contributing factor in the lymph node metastases process?
por: Mesker, Wilma E., et al.
Publicado: (2019)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2018)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
por: van Pelt, G.W., et al.
Publicado: (2019)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado: (2021)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Mesker, Wilma E., et al.
Publicado: (2009)

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer
por: Hagenaars, Sophie C., et al.
Publicado: (2021)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors
por: Grenader, Tal, et al.
Publicado: (2020)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
por: Vogelaar, F Jeroen, et al.
Publicado: (2010)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study
por: Dang, Hao, et al.
Publicado: (2021)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
por: Mesker, Wilma E., et al.
Publicado: (2007)

The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth
por: Bowers, Laura W., et al.
Publicado: (2018)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

Geometric tumor embolic budding characterizes inflammatory breast cancer
por: Modi, Arnav P., et al.
Publicado: (2022)

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013)

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells
por: Ansems, Marleen, et al.
Publicado: (2015)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Significance of Tumor–Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Nastały, Paulina, et al.
Publicado: (2021)

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
por: Andreano, Kaitlyn J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cfi2knl8gca3m8b9kulhr0j9br